SEC Form 4 research
| Issuer | AYTU BIOPHARMA, INC |
|---|---|
| Tickers | AYTU, RSWN |
| Reporting owners | 28 |
| Officers and directors | 10 |
| Last public filing | 2026-07-31 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-07-30 | 2026-07-28 | Disbrow Joshua R. | A | 30,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | PYSZCZYMUKA GREG | A | 20,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | Disbrow Jarrett | A | 15,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | Selhorn Ryan J | A | 25,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | LIU VIVIAN H | A | 10,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | JAIN ABHINAV | A | 10,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | DOCKERY CARL | A | 10,000 | $0 | Not reported |
| 2026-07-30 | 2026-07-28 | Donofrio John Jr. | A | 10,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.